MedTrace Logo

A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms

NCT07228312 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-05-13

No results posted yet for this study

Summary

The purpose of this study is to assess how safe choydar flow-directed mesh stent is and how well it works in the treatment of unruptured intracranial aneurysms (a condition in which a bulging blood vessel in the brain can burst and cause bleeding) in a real-world setting.

Conditions

  • Intracranial Aneurysm

Sponsors & Collaborators

  • Johnson & Johnson Medical (Shanghai) Ltd.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Medical (Shanghai) Ltd. Clinical Trial · Johnson & Johnson Medical (Shanghai) Ltd.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-28
Primary Completion
2028-02-10
Completion
2028-02-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07228312 on ClinicalTrials.gov